Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has…
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
Ironwood Academy Launches to Redefine Financial Learning
New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- How Is Ironwood…
ACKO Drive Launches 99 Car Spa Offer
BENGALURU, India, Oct. 24, 2025 /PRNewswire/ -- ACKO Drive has launched an…
LA28 celebrates 1,000 days to go with youth sports and Olympians
21 October 2025 - Marking 1,000 days to go until the LA28 Olympic Games begin,…
Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on…
Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza
Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance…
At the World Congress of Neurology, WHO Outlines a Global Roadmap to Make Brain Health a Universal Reality
SEOUL, South Korea and LONDON, Oct. 15, 2025 /PRNewswire/ -- Neurological conditions…
School Meals Save Lives and Strengthen Communities
On World Food Day, Education Cannot Wait calls for increased investment in…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…